Post by marriott on Feb 16, 2020 22:41:18 GMT
BREAKING NEWS
Check out Pharmaceutical Technology's news coverage on our recent announcement regarding the development of a coronavirus vaccine.
The PCR-produced linear DNA is expected to accelerate vaccine production.
Applied DNA Sciences has extended its partnership with Takis Biotech to include the development of a vaccine for 2019-nCoV coronavirus.
Applied DNA and LineaRx president and CEO Dr James Hayward said: “We have a patented and proprietary platform for the production of linear DNA that empowers rapid development and large-scale production that we believe will yield a safe and effective vaccine with fewer risks than other DNA production platfor
brian.viscount@adnas.com
631.240.8877
Check out Pharmaceutical Technology's news coverage on our recent announcement regarding the development of a coronavirus vaccine.
The PCR-produced linear DNA is expected to accelerate vaccine production.
Applied DNA Sciences has extended its partnership with Takis Biotech to include the development of a vaccine for 2019-nCoV coronavirus.
Applied DNA and LineaRx president and CEO Dr James Hayward said: “We have a patented and proprietary platform for the production of linear DNA that empowers rapid development and large-scale production that we believe will yield a safe and effective vaccine with fewer risks than other DNA production platfor
brian.viscount@adnas.com
631.240.8877